Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Anteris Technologies Global Corp. (AVR) vs Embecta Corp. (EMBC)

Anteris Technologies Global Corp. and Embecta Corp. are both Medical Instruments & Supplies companies. Anteris Technologies Global Corp. is the larger, with a market value of $745.6M against $316.2M — 2.4× the size. Anteris Technologies Global Corp. has negative trailing earnings, so its P/E is not meaningful; Embecta Corp. trades at 4.0×. Embecta Corp. grew revenue faster over the last twelve months: −7.60% against −9.56%. Embecta Corp. has the higher net margin (8.59% vs −4,619.3%) and the higher return on invested capital (21.4% vs 0.00%). Across the 16 metrics below, Embecta Corp. leads on 12 and Anteris Technologies Global Corp. on 4.

Valuation

Metric AVR EMBC Medical Instruments & Supplies median
P/E n/m 3.97 34.17
P/S 333.87 0.34 2.83
P/B 2.97 n/m 2.82
Price to free cash flow n/m 1.98 25.69
EV/EBITDA n/m 5.59 16.08
EV/Sales 219.27 1.58 3.06
Earnings yield (25.36%) 25.21% (1.84%)
Free cash flow yield (11.79%) 50.55% 0.17%

Profitability

Metric AVR EMBC Medical Instruments & Supplies median
Gross margin 74.98% 59.03% 54.62%
Operating margin (4,738.36%) 21.94% 1.64%
Net margin (4,619.27%) 8.59% 0.00%
Free cash flow margin (3,937.07%) 17.15% 1.61%
Return on equity (75.13%) (13.65%) 0.00%
Return on assets (66.31%) 7.22% 0.00%
Return on invested capital 0.00% 21.44% 0.00%

Growth

Metric AVR EMBC Medical Instruments & Supplies median
Revenue growth (TTM) (9.56%) (7.60%) 9.20%
EPS growth (last fiscal year) 30.71% 20.90% —
Revenue growth, 5-year CAGR — (1.50%) 9.48%
Net income growth, 5-year CAGR — (25.47%) 0.00%

Health

Metric AVR EMBC Medical Instruments & Supplies median
Debt to equity 0.00 (2.42) 0.08
Current ratio 14.20 1.68 2.49
Net debt to EBITDA 0.14 3.96 0.83

Dividend

Metric AVR EMBC Medical Instruments & Supplies median
Dividend yield — 3.04% 0.99%
Payout ratio — 0.69 0.00

Size

Metric AVR EMBC Medical Instruments & Supplies median
Market cap 745.56m 316.16m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack